Skip to main content

Table 1 Clinical and laboratory features on admission

From: Lactobacillus caseistrain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]

  Placebo group N LGG group N P
Age (months) 14.7 ± 6.4 89 14.9 ± 7.5 90 0.878
Duration of diarrhea before admission (h) 29.5 ± 14.9 89 28.8 ± 14.9 90 0.733
N° of stool motions 24 h before admission 6.6 ± 3.2 89 7.5 ± 3.9 90 0.101
N° of patients with vomitus 24 h before admission 64 (71.9%) 89 66 (73.3%) 90 0.963
N° of patients with fever 24 h before admission 39 (43.8%) 89 43 (47.8%) 90 0.703
Clinical dehydration   89   90 0.165
   Mild 48 (53.9%)   36 (40.0%)   
   Moderate 40 (44.9%)   52 (57.8%)   
   Severe 1 (1.1%)   2 (2.2%)   
% of weight gain after rehydration 3.0 ± 2.2 89 3.1 ± 2.3 90 0.763
Fever at admission (≥ 37.5°C) 16 (18.0%) 89 14 (15.9%) 88 0.868
Weight for height* 94.8 ± 9.3 89 94.1 ± 7.6 90 0.551
Height for age* 88.9 ± 12.1 89 97.2 ± 3.7 90 0.546
Weight for age* 88.9 ± 12.1 89 88.9 ± 10.8 90 0.952
Stool output (ml/kg) first 4 h (rehydration phase) 14.4 ± 12.4 89 18.1 ± 16.1 90 0.085
Hematocrit (%) 35.0 ± 4.2 89 35.5 ± 3.8 90 0.426
Plasma specific gravity 1.028 ± 0.002 89 1.028 ± 0.002 90 0.769
Serum Na+ (mEq/l) 136.6 ± 4.7 89 136.4 ± 4.6 87 0.770
Serum K+ (mEq/l) 4.0 ± 0.7 89 4.0 ± 0.7 87 0.985
Serum Cl (mEq/l) 102.5 ± 5.2 89 102.6 ± 5.4 87 0.874
Serum total CO2 (mmol/l) 14.0 ± 3.9 88 14.0 ± 3.9 87 0.971
Blood urea nitrogen (mg/dl) 13.1 ± 10.5 70 11.4 ± 6.6 73 0.253
Blood glucose (mg/dl) 107.5 ± 33.4 88 106.5 ± 35.9 88 0.848
N° of patients with fecal leukocytes (> 20 PMN/hpf) 30 (34.5%) 87 21 (23.6%) 89 0.154
N° of patients with microscopic fat 56 (64.4%) 87 52 (58.4%) 89 0.513
Fecal pH 6.3 ± 1.1 87 6.6 ± 1.1 89 0.126
N° of patients with CHO malabsorption 39 (45.9%) 85 36 (41.4%) 87 0.659
  1. * % of NCHS median
  2. Values are mean ± SD or n (%)